RELAPSED OR REFRACTORY HODGKIN LYMPHOMA

Clinical trials for RELAPSED OR REFRACTORY HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

New drug combo tested to fight returning blood cancer

Disease control Recruiting now

This study is testing whether adding the immunotherapy drug pembrolizumab to a standard chemotherapy combination (called GVD) works better for adults with Hodgkin lymphoma that has returned or didn't respond to their first treatment. The goal is to control the cancer and prepare …

Matched conditions: RELAPSED OR REFRACTORY HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

RELAPSED OR REFRACTORY HODGKIN LYMPHOMA

Get alerted when new RELAPSED OR REFRACTORY HODGKIN LYMPHOMA trials appear

New drug combo tested to fight returning blood cancer